Cardiac expression profiles of the naked DNA vectors encoding vascular endothelial growth factor and basic fibroblast growth factor

Jung Sun Lee, Jonghoe Byun, Jung Min Kim, Chae Young Kim, Byong Moon Kim, Ji Hyung Chung, Yangsoo Jang, Duk Kyung Kim

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We investigated expression profiles and biological effects of the naked DNA vectors in the heart. To this end, naked DNA vector was injected into the apex of the beating rat heart after thorocotomy. When the expression of LacZ reporter was examined by reverse transcription-PCR and histochemical staining for β-galactosidase, LacZ expression was detected only in the heart, suggesting limited dissemination of the injected vector in vivo. Even within the heart, LacZ expression was limited to the injection area (apex). Similar observations were made with other transgenes such as VEGF and basic fibroblast growth factor (bFGF), where 77% and 69% of the total transgene exprssion were detected in the heart segments containing the apex. Although VEGF and bFGF expressions were detected until 2 weeks after DNA injection, the highest levels of VEGF and bFGF were observed on day 5 and day 1, respectively. The optimal doses of the vectors were 10 μg and 25 μg for the VEGF and bFGF vectors, respectively. Interestingly, injection of bFGF vector led to 50% increase in the level of endogenous murine VEGF expression. Consistent with this finding, the number of vessels that stained positive for α-smooth muscle actin was increased in the bFGF vector-injected heart. These results suggest that simple injection of naked DNA vector may be sufficient to induce significant angiogenesis in the myocardium and that naked DNA gene therapy may be a feasible approach for the treatment of ischemic heart disease.

Original languageEnglish
Pages (from-to)447-456
Number of pages10
JournalExperimental and Molecular Medicine
Volume37
Issue number5
DOIs
Publication statusPublished - 2005 Oct 31

Fingerprint

Fibroblast Growth Factor 2
Vascular Endothelial Growth Factor A
DNA
Injections
Transgenes
Genetic Therapy
Galactosidases
Gene therapy
Reverse Transcription
Myocardial Ischemia
Smooth Muscle
Actins
Myocardium
Transcription
Staining and Labeling
Muscle
Rats
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Lee, Jung Sun ; Byun, Jonghoe ; Kim, Jung Min ; Kim, Chae Young ; Kim, Byong Moon ; Chung, Ji Hyung ; Jang, Yangsoo ; Kim, Duk Kyung. / Cardiac expression profiles of the naked DNA vectors encoding vascular endothelial growth factor and basic fibroblast growth factor. In: Experimental and Molecular Medicine. 2005 ; Vol. 37, No. 5. pp. 447-456.
@article{5f0e49628ad6441c92b32a2873a9a7ea,
title = "Cardiac expression profiles of the naked DNA vectors encoding vascular endothelial growth factor and basic fibroblast growth factor",
abstract = "We investigated expression profiles and biological effects of the naked DNA vectors in the heart. To this end, naked DNA vector was injected into the apex of the beating rat heart after thorocotomy. When the expression of LacZ reporter was examined by reverse transcription-PCR and histochemical staining for β-galactosidase, LacZ expression was detected only in the heart, suggesting limited dissemination of the injected vector in vivo. Even within the heart, LacZ expression was limited to the injection area (apex). Similar observations were made with other transgenes such as VEGF and basic fibroblast growth factor (bFGF), where 77{\%} and 69{\%} of the total transgene exprssion were detected in the heart segments containing the apex. Although VEGF and bFGF expressions were detected until 2 weeks after DNA injection, the highest levels of VEGF and bFGF were observed on day 5 and day 1, respectively. The optimal doses of the vectors were 10 μg and 25 μg for the VEGF and bFGF vectors, respectively. Interestingly, injection of bFGF vector led to 50{\%} increase in the level of endogenous murine VEGF expression. Consistent with this finding, the number of vessels that stained positive for α-smooth muscle actin was increased in the bFGF vector-injected heart. These results suggest that simple injection of naked DNA vector may be sufficient to induce significant angiogenesis in the myocardium and that naked DNA gene therapy may be a feasible approach for the treatment of ischemic heart disease.",
author = "Lee, {Jung Sun} and Jonghoe Byun and Kim, {Jung Min} and Kim, {Chae Young} and Kim, {Byong Moon} and Chung, {Ji Hyung} and Yangsoo Jang and Kim, {Duk Kyung}",
year = "2005",
month = "10",
day = "31",
doi = "10.1038/emm.2005.55",
language = "English",
volume = "37",
pages = "447--456",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "5",

}

Cardiac expression profiles of the naked DNA vectors encoding vascular endothelial growth factor and basic fibroblast growth factor. / Lee, Jung Sun; Byun, Jonghoe; Kim, Jung Min; Kim, Chae Young; Kim, Byong Moon; Chung, Ji Hyung; Jang, Yangsoo; Kim, Duk Kyung.

In: Experimental and Molecular Medicine, Vol. 37, No. 5, 31.10.2005, p. 447-456.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cardiac expression profiles of the naked DNA vectors encoding vascular endothelial growth factor and basic fibroblast growth factor

AU - Lee, Jung Sun

AU - Byun, Jonghoe

AU - Kim, Jung Min

AU - Kim, Chae Young

AU - Kim, Byong Moon

AU - Chung, Ji Hyung

AU - Jang, Yangsoo

AU - Kim, Duk Kyung

PY - 2005/10/31

Y1 - 2005/10/31

N2 - We investigated expression profiles and biological effects of the naked DNA vectors in the heart. To this end, naked DNA vector was injected into the apex of the beating rat heart after thorocotomy. When the expression of LacZ reporter was examined by reverse transcription-PCR and histochemical staining for β-galactosidase, LacZ expression was detected only in the heart, suggesting limited dissemination of the injected vector in vivo. Even within the heart, LacZ expression was limited to the injection area (apex). Similar observations were made with other transgenes such as VEGF and basic fibroblast growth factor (bFGF), where 77% and 69% of the total transgene exprssion were detected in the heart segments containing the apex. Although VEGF and bFGF expressions were detected until 2 weeks after DNA injection, the highest levels of VEGF and bFGF were observed on day 5 and day 1, respectively. The optimal doses of the vectors were 10 μg and 25 μg for the VEGF and bFGF vectors, respectively. Interestingly, injection of bFGF vector led to 50% increase in the level of endogenous murine VEGF expression. Consistent with this finding, the number of vessels that stained positive for α-smooth muscle actin was increased in the bFGF vector-injected heart. These results suggest that simple injection of naked DNA vector may be sufficient to induce significant angiogenesis in the myocardium and that naked DNA gene therapy may be a feasible approach for the treatment of ischemic heart disease.

AB - We investigated expression profiles and biological effects of the naked DNA vectors in the heart. To this end, naked DNA vector was injected into the apex of the beating rat heart after thorocotomy. When the expression of LacZ reporter was examined by reverse transcription-PCR and histochemical staining for β-galactosidase, LacZ expression was detected only in the heart, suggesting limited dissemination of the injected vector in vivo. Even within the heart, LacZ expression was limited to the injection area (apex). Similar observations were made with other transgenes such as VEGF and basic fibroblast growth factor (bFGF), where 77% and 69% of the total transgene exprssion were detected in the heart segments containing the apex. Although VEGF and bFGF expressions were detected until 2 weeks after DNA injection, the highest levels of VEGF and bFGF were observed on day 5 and day 1, respectively. The optimal doses of the vectors were 10 μg and 25 μg for the VEGF and bFGF vectors, respectively. Interestingly, injection of bFGF vector led to 50% increase in the level of endogenous murine VEGF expression. Consistent with this finding, the number of vessels that stained positive for α-smooth muscle actin was increased in the bFGF vector-injected heart. These results suggest that simple injection of naked DNA vector may be sufficient to induce significant angiogenesis in the myocardium and that naked DNA gene therapy may be a feasible approach for the treatment of ischemic heart disease.

UR - http://www.scopus.com/inward/record.url?scp=27744570152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744570152&partnerID=8YFLogxK

U2 - 10.1038/emm.2005.55

DO - 10.1038/emm.2005.55

M3 - Article

C2 - 16264269

AN - SCOPUS:27744570152

VL - 37

SP - 447

EP - 456

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 5

ER -